已经报道 NMS 与每一种抗精神病药物均相关。
在治疗开始时给予高剂量的抗精神病药物以及肌肉注射给药可能增加风险。
没有单独的哪一种药物是明确的致病药物。有些人认为第二代抗精神病药物 (SGA) 的风险低于第一代抗精神病药物(first-generation antipsychotic,FGA;例如氟哌啶醇和匹莫齐特),尤其是高效的 FGA。一项大型病例对照研究发现与之相反的结果是正确的。[15]Nielsen RE, Wallenstein Jensen SO, et al. Neuroleptic malignant syndrome - an 11-year longitudinal case-control study. Can J Psychiatry. 2012;57:512-518.http://www.ncbi.nlm.nih.gov/pubmed/22854034?tool=bestpractice.com其他大型研究发现,FGA 相关 NMS 和 SGA 相关 NMS 之间的主要区别为,前者的强直更频繁[28]Trollor JN, Chen X, Chitty K, et al. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics. Br J Psychiatry. 2012;201:52-56.http://bjp.rcpsych.org/content/201/1/52.longhttp://www.ncbi.nlm.nih.gov/pubmed/22626633?tool=bestpractice.com,并且死亡率更高[20]Nakamura M, Yasunaga H, Miyata H, et al. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination Database. J Clin Psychiatry. 2012;73:427-430.http://www.ncbi.nlm.nih.gov/pubmed/22154901?tool=bestpractice.com[28]Trollor JN, Chen X, Chitty K, et al. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics. Br J Psychiatry. 2012;201:52-56.http://bjp.rcpsych.org/content/201/1/52.longhttp://www.ncbi.nlm.nih.gov/pubmed/22626633?tool=bestpractice.com。